Clinical Trials
Visterra doses first patient in phase IIa trial for VIS410 for Influenza A
Visterra, Inc , a clinical-stage biopharmaceutical company announced that the first patient was dosed in a Phase 2a clinical trial of VIS410, a monoclonal antibody in...
Clinical Trials
Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118
Valeant Pharmaceuticals International, Inc. announced positive results from a second confirmatory pivotal Phase 3, multicenter double-blind, randomized, vehicle-controlled clinical study to assess the safety and...
Clinical Trials
Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitment System platform
The iHealth Group of Brazil joins the Patient Recruitment System platform as Clinerion's first hospital cluster in South America. iHealth brings PRS...
Clinical Trials
Renova Therapeutics selects Worldwide Clinical Trials as its CRO for RT-100 AC6 gene transfer
Renova Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes. Announced that it has selected...
Clinical Trials
Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera for Treatment of Dry Eye
Sun Pharma (SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies), announced successful Phase 3 confirmatory clinical...
Clinical Trials
Protalix BioTherapeutics Announces Positive results from Phase II Clinical Trial of alidornase alfa
Protalix BioTherapeutics Inc announced positive interim results from the Company’s phase II clinical trial of alidornase alfa for the treatment of Cystic Fibrosis (CF) for...
Articles
Clinical research data sharing promises new cures and treatments
Clinical research generates extensive amounts of data, yet most of it is siloed or generally unavailable to a larger pool of willing potential researchers.
If this...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.